Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Texas Instruments Incorporated's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $236.5B | |
|---|---|---|
| Revenue (ttm) | 20.8B | |
| Net income (ttm) | 7.1B | |
| EPS (ttm) | $7.72 | |
| Shares out | 913.8M | |
| P/E (trailing) | 40.2x | |
| P/E (forward) | 26.1x | |
| Dividend | $6.08 (1.98%) | |
| Volume | 4,126,503 | |
| Beta | 1.34 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $18.34B | $20.03B | $17.52B | $15.64B | $17.68B | -0.9% |
| Gross profit | $12.38B | $13.77B | $11.02B | $9.09B | $10.08B | -5.0% |
| Operating income | $8.96B | $10.14B | $7.33B | $5.47B | $6.02B | -9.5% |
| Net income | $7.77B | $8.75B | $6.51B | $4.80B | $5.00B | -10.4% |
| EPS (diluted) | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 | -9.9% |
| EBITDA | $10.06B | $11.23B | $8.50B | $7.54B | $8.25B | -4.8% |
| R&D | $1.55B | $1.67B | $1.86B | $1.96B | $2.08B | +7.6% |
| SG&A | $1.67B | $1.70B | $1.83B | $1.79B | $1.86B | +2.8% |
Recent company headlines from major financial publishers.
The path is supported if FY2027 revenue and diluted EPS remain within their dated forecast ranges. Results below those ranges would weaken the expected recovery.
This path raises profit and cash without requiring investors to pay a higher valuation for each dollar of earnings. Persistent heavy reinvestment would disconfirm it.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.9% | $126 | $130 | $135 | $140 | $148 |
| 8.9% | $114 | $117 | $120 | $124 | $129 |
| 9.9% | $105 | $107 | $110 | $112 | $115 |
| 10.9% | $97.8 | $99.4 | $101 | $103 | $105 |
| 11.9% | $91.7 | $92.9 | $94.3 | $95.8 | $97.4 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
